https://www.opri.sg/jobs-3/trends-in-systemic-glucocorticoid-utilisation-in-the-united-kingdom-from-1990-to-2019%3A-a-population-based%2C-serial-cross-sectional-analysis 2024-05-27 https://www.opri.sg/jobs-3/type-2-inflammatory-disease-burden-among-asthma-patients-and-its-association-with-asthma-related-outcomes 2024-05-27 https://www.opri.sg/jobs-3/the-use-of-multiple-respiratory-inhalers-requiring-different-inhalation-techniques-has-an-adverse-effect-on-copd-outcomes 2024-05-27 https://www.opri.sg/jobs-3/real-life-comparison-of-beclometasone-dipropionate-as-an-extrafine--or-larger-particle-formulation-for-asthma 2024-05-27 https://www.opri.sg/jobs-3/conquest%3A-a-quality-improvement-program-for-defining-and-optimizing-standards-of-care-for-modifiable-high-risk-copd-patients 2024-05-27 https://www.opri.sg/jobs-3/-evaluation-of-inhaler-technique-and-achievement-and-maintenance-of-mastery-of-budesonide%2Fformoterol-spiromax%C2%AE-compared-with-budesonide%2Fformoterol-turbuhaler%C2%AE-in-adult-patients-with-asthma%3A-the-easy-low-instruction-over-time-(eliot)-study 2024-05-27 https://www.opri.sg/jobs-3/observational-study-comparing-intranasal-mometasone-furoate-with-oral-antihistamines-for-rhinitis-and-asthma 2024-05-27 https://www.opri.sg/jobs-3/defining-a-severe-asthma-super-responder%3A-findings-from-a-delphi-process 2024-05-27 https://www.opri.sg/jobs-3/cardiovascular-risks-in-smokers-treated-with-nicotine-replacement-therapy%3A-a-historical-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/exploring-definitions-and-predictors-of-response-to-biologics-for-severe-asthma-(full-beam-i) 2024-05-27 https://www.opri.sg/jobs-3/the-use-of-roflumilast-in-copd%3A-a-primary-care-perspective 2024-05-27 https://www.opri.sg/jobs-3/health-care-resource-utilization-and-costs-associated-with-incremental-systemic-corticosteroid-exposure-in-asthma 2024-05-27 https://www.opri.sg/jobs-3/risk-of-pneumonia-in-patients-with-copd-initiating-fixed-dose-inhaled-corticosteroid-(ics)-%2F-long-acting-bronchodilator-(labd)-formulations-containing-extrafine-beclometasone-dipropionate-versus-patients-initiating-labd-without-ics 2024-05-27 https://www.opri.sg/jobs-3/-initial-step-up-treatment-changes-in-asthmatic-children-already-prescribed-inhaled-corticosteroids%3A-a-historical-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/characterisation-of-the-australian-adult-population-living-with-asthma%3A-exacerbation-frequency%2C-long-term-ocs-use-and-adverse-effects 2024-05-27 https://www.opri.sg/jobs-3/an-evaluation-of-exact-matching-and-propensity-score-methods-as-applied-in-a-comparative-effectiveness-study-of-inhaled-corticosteroids-in-asthma. 2024-05-27 https://www.opri.sg/jobs-3/cluster-randomized-trial-evaluating-the-impact-of-dual-bronchodilator-with-add-on-sensor-and-electronic-monitoring-on-clinical-outcomes 2024-05-27 https://www.opri.sg/jobs-3/conquest-quality-standards%3A-for-the-collaboration-on-quality-improvement-initiative-for-achieving-excellence-in-standards-of-copd-care 2024-05-27 https://www.opri.sg/jobs-3/hormonal-contraceptives-and-onset-of-asthma-in-reproductive-age-women%3A-population-based-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/seasonal-patterns-of-oral-antihistamine-and-intranasal-corticosteroid-purchases-from-australian-community-pharmacies%3A-a-retrospective-observational-study 2024-05-27 https://www.opri.sg/jobs-3/impact-of-comorbidity-in-severe-asthma-patients-(prism)%3A-association-between-t2-related-co-morbidities-and-effectiveness-of-biologics-in-adult-patients-from-the-international-severe-asthma-registry 2024-05-27 https://www.opri.sg/jobs-3/a-response-to%3A-letter-to-the-editor-regarding-clinical-remission-and-benralizumab%3A-an-independent-post-hoc-analysis-on-severe-asthma 2024-05-27 https://www.opri.sg/jobs-3/patients-with-chronic-obstructive-pulmonary-disease-and-evidence-of-eosinophilic-inflammation-experience-exacerbations-despite-receiving-maximal-inhaled-maintenance-therapy 2024-05-27 https://www.opri.sg/jobs-3/small-particle-inhaled-corticosteroid-as-first-line-or-step-up-controller-therapy-in-childhood-asthma 2024-05-27 https://www.opri.sg/jobs-3/international-severe-asthma-registry%3A-mission-statement 2024-05-27 https://www.opri.sg/jobs-3/international-severe-asthma-registry-(isar)%3A-protocol-for-a-global-registry 2024-05-27 https://www.opri.sg/jobs-3/-fluticasone-propionate%2Fformoterol-fumarate-in-fixed-dose-combination-for-the-treatment-of-asthma 2024-05-27 https://www.opri.sg/jobs-3/reply-%5Binhaled-corticosteroids-for-asthma-therapy-in-young-children%3A-does-aerosol-particle-size-matter%3F 2024-05-27 https://www.opri.sg/jobs-3/patterns-of-care-in-the-management-of-high-risk-copd-in-the-us-(2011-2019)%3A-an-observational-study-for-the-conquest-quality-improvement-program. 2024-05-27 https://www.opri.sg/jobs-3/cost-effectiveness-of-initiating-extrafine--or-standard-size-particle-inhaled-corticosteroid-for-asthma-in-two-health-care-systems%3A-a-retrospective-matched-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/underuse-of-%CE%B2-blockers-in-heart-failure-and-chronic-obstructive-pulmonary-disease 2024-05-27 https://www.opri.sg/jobs-3/comparative-effectiveness-of-triple-therapy-versus-dual-bronchodilation-in-copd 2024-05-27 https://www.opri.sg/jobs-3/effectiveness-of-inhaler-types-for-real-world-asthma-management%3A-retrospective-observational-study-using-the-gprd 2024-05-27 https://www.opri.sg/jobs-3/asthma-related-outcomes-in-patients-initiating-extrafine-ciclesonide-or-fine-particle-inhaled-corticosteroids 2024-05-27 https://www.opri.sg/jobs-3/-comparative-safety-of-extrafine-beclometasone-fixed-dose-combinations-(fdc)-and-fluticasone-fdc-in-copd. 2024-05-27 https://www.opri.sg/jobs-3/adequacy-of-therapy-for-people-with-both-copd-and-heart-failure-in-the-uk%3A-historical-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/short-acting-%CE%B22-agonist-prescriptions-are-associated-with-poor-clinical-outcomes-of-asthma%3A-the-multi-country%2C-cross-sectional-sabina-iii-study 2024-05-27 https://www.opri.sg/jobs-3/the-long-term-burden-of-copd-exacerbations-during-maintenance-therapy-and-lung-function-decline 2024-05-27 https://www.opri.sg/jobs-3/cost-effectiveness-of-asthma-step-up-therapy-as-an-increased-dose-of-extrafine-particle-inhaled-corticosteroid-or-add-on-long-acting-beta2-agonist 2024-05-27 https://www.opri.sg/jobs-3/management-of-community-acquired-pneumonia%3A-an-observational-study-in-uk-primary-care 2024-05-27 https://www.opri.sg/jobs-3/a-randomized-pragmatic-trial-of-changing-to-and-stepping-down-fluticasone%2Fformoterol-in-asthma 2024-05-27 https://www.opri.sg/jobs-3/blood-eosinophil-count-and-prospective-annual-asthma-disease-burden%3A-a-uk-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/an-observational-uk-cohort-study-to-describe-intermittent-oral-corticosteroid-prescribing-patterns-and-their-association-with-adverse-outcomes-in-asthma 2024-05-27 https://www.opri.sg/jobs-3/-identifying-risk-of-future-asthma-attacks-using-uk-medical-record-data%3A-a-respiratory-effectiveness-group-initiative 2024-05-27 https://www.opri.sg/jobs-3/development-of-the-advancing-the-patient-experience-(apex)-in-copd-registry%3A-a-modified-delphi-study 2024-05-27 https://www.opri.sg/jobs-3/-using-fractional-exhaled-nitric-oxide-(feno)-to-diagnose-steroid-responsive-disease-and-guide-asthma-management-in-routine-care 2024-05-27 https://www.opri.sg/jobs-3/effect-of-inhaled-corticosteroid-therapy-step-down-and-dosing-regimen-on-measures-of-asthma-control 2024-05-27 https://www.opri.sg/jobs-3/cost-effectiveness-of-leukotriene-receptor-antagonists-versus-inhaled-corticosteroids-for-initial-asthma-controller-therapy%3A-a-pragmatic-trial 2024-05-27 https://www.opri.sg/jobs-3/a-comparison-of-the-real-life-clinical-effectiveness-of-the-leading-licensed-ics%2Flaba-combination-inhalers-in-the-treatment-for-copd 2024-05-27 https://www.opri.sg/jobs-3/incidence-of-oral-thrush-in-patients-with-copd-prescribed-inhaled-corticosteroids%3A-effect-of-drug%2C-dose%2C-and-device 2024-05-27 https://www.opri.sg/jobs-3/comparative-safety-of-extrafine-beclometasone-fixed-dose-combinations-(fdc)-and-fluticasone-fdc-in-copd 2024-05-27 https://www.opri.sg/jobs-3/comparative-effectiveness-of-step-up-therapies-in-children-with-asthma-prescribed-inhaled-corticosteroids%3A-a-historical-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/predicting-frequent-copd-exacerbations-using-primary-care-data 2024-05-27 https://www.opri.sg/jobs-3/performance-of-database-derived-severe-exacerbations-and-asthma-control-measures-in-asthma%3A-responsiveness-and-predictive-utility-in-a-uk-primary-care-database-with-linked-questionnaire-data. 2024-05-27 https://www.opri.sg/jobs-3/inhaled-corticosteroids-in-copd-and-onset-of-type-2-diabetes-and-osteoporosis%3A-matched-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/chester-fox%2C-wilson-pace%2C-elias-brandt%2C-victoria-carter%2C-ku-lang-chang%2C-chelsea-edwards%2C-alexander-evans%2C-gabriela-gaona%2C-meilan-k.-han%2C-alan-kaplan%2C-rachel-kent%2C-janwillem-kocks%2C-maja-kruszyk%2C-chantal-le-lievre%2C-tessa-li-voti%2C-cathy-mahle%2C-barry-make%2C-amanda-ratigan%2C-asif-shaikh%2C-neil-skolnik%2C-brooklyn-stanley%2C-barbara-p.-yawn%2C-david-price 2024-05-27 https://www.opri.sg/jobs-3/improving-clinician-patient-communication-in-asthma%3A-the-harp-project. 2024-05-27 https://www.opri.sg/jobs-3/the-association-between-short-acting-%CE%B22-agonist-over-prescription%2C-and-patient-reported-acquisition-and-use-on-asthma-control-and-exacerbations%3A-data-from-australia 2024-05-27 https://www.opri.sg/jobs-3/comparative-safety-profile-of-the-fixed-dose-combination-corticosteroid-and-long-acting%C2%A0%CE%B22-agonist-fluticasone-propionate%2Fformoterol-fumarate%3A-a-36-month-longtiduinal-cohort-study-in-uk-primary-care 2024-05-27 https://www.opri.sg/jobs-3/long-acting-%CE%B2-agonist-in-combination-or-separate-inhaler-as-step-up-therapy-for-children-with-uncontrolled-asthma-receiving-inhaled-corticosteroids 2024-05-27 https://www.opri.sg/jobs-3/identification-of-key-opportunities-for-optimising-the-management-of-high-risk-copd-patients-in-the-uk-using-the-conquest-quality-standards%3A-an-observational-longitudinal-study 2024-05-27 https://www.opri.sg/jobs-3/device-type-and-real-world-effectiveness-of-asthma-combination-therapy%3A-an-observational-study 2024-05-27 https://www.opri.sg/jobs-3/impact-of-initiating-biologics-in-patients-with-severe-asthma-and-on-long-term-ocs-or-frequent-rescue-steroids 2024-05-27 https://www.opri.sg/jobs-3/chester-fox%2C-wilson-pace%2C-elias-brandt%2C-victoria-carter%2C-ku-lang-chang%2C-chelsea-edwards%2C-alexander-evans%2C-gabriela-gaona%2C-meilan-k.-han%2C-alan-kaplan%2C-rachel-kent%2C-janwillem-kocks%2C-maja-kruszyk%2C-chantal-le-lievre%2C-tessa-li-voti%2C-cathy-mahle%2C-barry-make%2C-amanda-ratigan%2C-asif-shaikh%2C-neil-skolnik%2C-brooklyn-stanley%2C-barbara-p.-yawn%2C-david-price.-variation-in-demographic-and-clinical-characteristics-of-patients-with-copd-receiving-care-in-u.s.-primary-care%3A-data-from-the-advancing-the-patient-experience-(apex)-in-copd-registry.-prag-obs-res-2022.- 2024-05-27 https://www.opri.sg/jobs-3/applying-uk-real-world-primary-care-data-to-predict-asthma-attacks-in-3776-well-characterised-children%3A-a-retrospective-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/cohort-analysis-of-exacerbation-rates-in-adolescent-and-adult-patients-initiating-inhaled-corticosteroids-for-asthma%3A-different-dose-response-profile-by-particle-size 2024-05-27 https://www.opri.sg/jobs-3/real-life-treatment-of-rhinitis-in-australia%3B-a-historical-cohort-study-of-prescription-and-over-the-counter-therapies 2024-05-27 https://www.opri.sg/jobs-3/the-effect-of-smoking-on-exacerbation-risk-in-eosinophilic-patients-with-chronic-obstructive-pulmonary-disease 2024-05-27 https://www.opri.sg/jobs-3/adverse-outcomes-from-initiation-of-systemic-corticosteroids-for-asthma%3A-long-term-observational-study 2024-05-27 https://www.opri.sg/jobs-3/spirometry%3A-an-essential-tool-for-screening%2C-case-finding%2C-and-diagnosis-of-copd 2024-05-27 https://www.opri.sg/jobs-3/-asthma-outcomes-and-costs-of-therapy-with-extrafine-beclomethasone-and-fluticasone 2024-05-27 https://www.opri.sg/jobs-3/blood-eosinophil-count-predicts-treatment-failure-and-hospital-readmission-for-copd 2024-05-27 https://www.opri.sg/jobs-3/opportunities-to-diagnose-chronic-obstructive-pulmonary-disease-in-routine-care-in-the-uk%3A-a-retrospective-study-of-a-clinical-cohort 2024-05-27 https://www.opri.sg/jobs-3/clinical-and-cost-effectiveness-of-switching-asthma-patients-from-fluticasone-salmeterol-to-extra-fine-particle-beclometasone-formoterol%3A-a-retrospective-matched-observational-study-of-real-world-patients 2024-05-27 https://www.opri.sg/jobs-3/asthma-exacerbations-are-associated-with-a-decline-in-lung-function%3A-a-longitudinal-population-based-study 2024-05-27 https://www.opri.sg/jobs-3/erratum%3A-changes-in-initial-copd-treatment-choice-over-time-and-factors-influencing-prescribing-decisions-in-uk-primary-care%3A-a-real-world-study 2024-05-27 https://www.opri.sg/jobs-3/analysis-of-comorbidities-and-multimorbidity-in-adult-patients-in-the-international-severe-asthma-registry 2024-05-27 https://www.opri.sg/jobs-3/a-long-term-study-of-adverse-outcomes-associated-with-oral-corticosteroid-use-in-copd 2024-05-27 https://www.opri.sg/jobs-3/the-comparative-effectiveness-of-initiating-fluticasone%2Fsalmeterol-combination-therapy-via-pmdi-versus-dpi-in-reducing-exacerbations-and-treatment-escalation-in-copd%3A-a-uk-database-study 2024-05-27 https://www.opri.sg/jobs-3/real-life-effectiveness-of-inhaler-device-switch-from-dry-powder-inhalers-to-pressurised-metered-dose-inhalers-in-patients-with-asthma-treated-with-ics%2Flaba 2024-05-27 https://www.opri.sg/jobs-3/effect-of-stepping-up-to-high-dose-inhaled-corticosteroids-in-patients-with-asthma 2024-05-27 https://www.opri.sg/jobs-3/effectiveness-of-initiating-extrafine-particle-versus-fine-particle-inhaled-corticosteroids-as-asthma-therapy-in-the-netherlands 2024-05-27 https://www.opri.sg/jobs-3/distribution%2C-temporal-stability-and-appropriateness-of-therapy-of-patients-with-copd-in-the-uk-in-relation-to-gold-2019 2024-05-27 https://www.opri.sg/jobs-3/historical-cohort-study-examining-comparative-effectiveness-of-albuterol-inhalers-with-and-without-integrated-dose-counter-for-patients-with-asthma-or-chronic-obstructive-pulmonary-disease 2024-05-27 https://www.opri.sg/jobs-3/development-of-the-international-severe-asthma-registry-(isar)%3A-a-modified-delphi-study 2024-05-27 https://www.opri.sg/jobs-3/evaluating-the-real-life-effect-of-mp-azeflu-on-asthma-outcomes-in-patients-with-allergic-rhinitis-and-asthma-in-uk-primary-care 2024-05-27 https://www.opri.sg/jobs-3/cost-effectiveness-analysis-of-corticosteroid-inhaler-devices-in-primary-care-asthma-management%3A-a-real-world-observational-study 2024-05-27 https://www.opri.sg/jobs-3/the-comparative-effectiveness-of-anti-il5-and-anti-ige-biologic-classes-in-severe-asthma-patients-eligible-for-both 2024-05-27 https://www.opri.sg/jobs-3/characterization-of-patients-in-the-international-severe-asthma-registry-with-high-steroid-exposure-who-did-or-did-not-initiate-biologic-therapy 2024-05-27 https://www.opri.sg/jobs-3/a-multinational-observational-study-identifying-primary-care-patients-at-risk-of-overestimation-of-asthma-control 2024-05-27 https://www.opri.sg/jobs-3/adjunctive-treatment-with-oral-akl1%2C-a-botanical-nutraceutical%2C-in-chronic-obstructive-pulmonary-disease 2024-05-27 https://www.opri.sg/jobs-3/association-of-elevated-fractional-exhaled-nitric-oxide-concentration-and-blood-eosinophil-count-with-severe-asthma-exacerbation 2024-05-27 https://www.opri.sg/jobs-3/matched-cohort-study-of-therapeutic-strategies-to-prevent-preschool-wheezing%2Fasthma-attacks 2024-05-27 https://www.opri.sg/jobs-3/differential-effects-of-inhaled-corticosteroids-in-smokers%2Fex-smokers-and-nonsmokers-with-asthma 2024-05-27 https://www.opri.sg/jobs-3/efficacy-versus-effectiveness-trials%3A-informing-guidelines-for-asthma-management 2024-05-27 https://www.opri.sg/jobs-3/global-variability-in-administrative-approval-prescription-criteria-for-biologic-therapy-in-severe-asthma 2024-05-27 https://www.opri.sg/jobs-3/risk-of-pneumonia-in-obstructive-lung-disease%3A-a-real-life-study-comparing-extra-fine-and-fine-particle-inhaled-corticosteroids 2024-05-27 https://www.opri.sg/jobs-3/adult-severe-asthma-registries%3A-a-global-and-growing-inventory 2024-05-27 https://www.opri.sg/jobs-3/blood-eosinophil-count-and-exacerbation-risk-in-patients-with-copd 2024-05-27 https://www.opri.sg/jobs-3/real-world-biologics-response-and-super-response-in-the-international-severe-asthma-registry-cohort-(luminant) 2024-05-27 https://www.opri.sg/jobs-3/does-changing-inhaler-device-impact-real-life-asthma-outcomes-clinical-and-economic-evaluation 2024-05-27 https://www.opri.sg/jobs-3/add-on-laba-in-a-separate-inhaler-as-asthma-step-up-therapy-versus-increased-dose-of-ics-or-ics%2Flaba-combination-inhaler 2024-05-27 https://www.opri.sg/jobs-3/the-association-between-short-acting-%CE%B22-agonist-over-prescription%2C-and-patient-reported-acquisition-and-use-on-asthma-control-and-exacerbations%3A-data-from-australia 2024-05-27 https://www.opri.sg/jobs-3/cost-effectiveness-of-leukotriene-receptor-antagonists-versus-long-acting-beta-2-agonists-as-add-on-therapy-to-inhaled-corticosteroids-for-asthma%3A-a-pragmatic-trial 2024-05-27 https://www.opri.sg/jobs-3/association-between-pre-biologic-t2-biomarker-combinations-and-response-to-biologics-in-patients-with-severe-asthma-(ignite) 2024-05-27 https://www.opri.sg/jobs-3/application-of-an-algorithm-to-analyse-patterns-of-intermittent-oral-corticosteroid-use-in-asthma 2024-05-27 https://www.opri.sg/jobs-3/characterization-of-severe-asthma-worldwide%3A-data-from-the-international-severe-asthma-registry 2024-05-27 https://www.opri.sg/jobs-3/-inappropriate-asthma-therapy-%E2%80%94-a-tale-of-two-countries%3A-a-parallel-population-based-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/uk-prescribing-practices-as-proxy-markers-of-unmet-need-in-allergic-rhinitis%3A-a-retrospective-observational-study 2024-05-27 https://www.opri.sg/jobs-3/prescribing-trends-in-asthma%3A-a-longitudinal-observational-study 2024-05-27 https://www.opri.sg/jobs-3/a-survey-on-the-management-of-acute-rhinosinusitis-among-asian-physicians 2024-05-27 https://www.opri.sg/jobs-3/concept-review-of-dry-powder-inhalers%3A-correct-interpretation-of-published-data 2024-05-27 https://www.opri.sg/jobs-3/identifying-patient-attitudinal-clusters-associated-with-asthma-control%3A-the-european-realise-survey 2024-05-27 https://www.opri.sg/jobs-3/metabolic-effects-associated-with-ics-in-patients-with-copd-and-comorbid-type-2-diabetes%3A-a-historical-matched-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/trends-of-testing-for-and-diagnosis-of-alpha-1-antitrypsin-deficiency-in-the-uk%3A-more-testing-is-needed 2024-05-27 https://www.opri.sg/jobs-3/persistence-of-eosinophilic-asthma-endotype-and-clinical-outcomes%3A-a-real-world-observational-study 2024-05-27 https://www.opri.sg/jobs-3/fractional-exhaled-nitric-oxide-as-a-predictor-of-response-to-inhaled-corticosteroids-in-patients-with-non-specific-respiratory-symptoms-and-insignificant-bronchodilator-reversibility%3A-a-randomised-controlled-trial 2024-05-27 https://www.opri.sg/jobs-3/real-life-asthma-strategies%3A-the-missing-piece-in-the-jigsaw 2024-05-27 https://www.opri.sg/jobs-3/ipratropium%2Fsalbutamol-comparator-versus-originator-for-chronic-obstructive-pulmonary-disease-exacerbations%3A-us-observational-cohort-study-using-the-clinformatics%E2%84%A2-health-claims-database 2024-05-27 https://www.opri.sg/jobs-3/advancing-the-patient-experience-(apex)-in-copd-registry%3A-study-design-and-strengths 2024-05-27 https://www.opri.sg/jobs-3/potential-severe-asthma-hidden-in-uk-primary-care 2024-05-27 https://www.opri.sg/jobs-3/inhaler-errors-in-the-critikal-study%3A-type%2C-frequency%2C-and-association-with-asthma-outcomes 2024-05-27 https://www.opri.sg/jobs-3/real-life-outcomes-for-patients-with-asthma-prescribed-spacers-for-use-with-either-extrafine--or-fine-particle-inhaled-corticosteroids 2024-05-27 https://www.opri.sg/jobs-3/impact-of-pre-biologic-impairment-on-meeting-domain-specific-biologic-responder-definitions-in-patients-with-severe-asthma 2024-05-27 https://www.opri.sg/jobs-3/data-resource-profile%3A-optimum-patient-care-research-database-(opcrd)%E2%80%8B 2024-05-27 https://www.opri.sg/jobs-3/measuring-peak-inspiratory-flow-in-patients-with-chronic-obstructive-pulmonary-disease. 2024-05-27 https://www.opri.sg/jobs-3/international-variation-in-severe-exacerbation-rates-in-patients-with-severe-asthma 2024-05-27 https://www.opri.sg/jobs-3/changes-in-initial-copd-treatment-choice-over-time-and-factors-influencing-prescribing-decisions-in-uk-primary-care%3A-in-uk-primary-care%3A-a-real-world%2C-retrospective%2C-observational 2024-05-27 https://www.opri.sg/jobs-3/prescribing-practices-and-asthma-control-with-hydrofluoroalkane-beclomethasone-and-fluticasone%3A-a-real-world-observational-study 2024-05-27 https://www.opri.sg/jobs-3/a-historical-database-cohort-study-addressing-the-clinical-patterns-prior-to-idiopathic-pulmonary-fibrosis-(ipf)-diagnosis-in-uk-primary-care 2024-05-27 https://www.opri.sg/jobs-3/exploring-definitions-and-predictors-of-severe-asthma-clinical-remission-post-biologic-in-adults-(full-beam-ii) 2024-05-27 https://www.opri.sg/jobs-3/asthma-control-with-extrafine-particle-hydrofluoroalkane-beclometasone-vs.-large-particle-chlorofluorocarbon-beclometasone%3A-a-real-world-observational-study 2024-05-27 https://www.opri.sg/jobs-3/eligibility-of-real-life-patients-with-copd-for-inclusion-in-trials-of-inhaled-long-acting-bronchodilator-therapy 2024-05-27 https://www.opri.sg/jobs-3/management-of-copd-in-the-uk-primary-care-setting%3A-an-analysis-of-real-life-prescribing-patterns 2024-05-27 https://www.opri.sg/jobs-3/comparing-the-effectiveness-of-small-particle-versus-large-particle-inhaled-corticosteroid-in-copd 2024-05-27 https://www.opri.sg/jobs-3/association-between-copd-exacerbations-and-lung-function-decline-during-maintenance-therapy 2024-05-27 https://www.opri.sg/jobs-3/comparison-of-serious-inhaler-technique-errors-made-by-device-na%C3%AFve-patients-using-three-different-dry-powder-inhalers%3A-a-randomised%2C-crossover%2C-open-label-study 2024-05-27 https://www.opri.sg/jobs-3/physiological-predictors-of-peak-inspiratory-flow-using-observed-lung-function-results-(poros)%3A-evaluation-at-discharge-among-patients-hospitalized-for-a-copd-exacerbation 2024-05-27 https://www.opri.sg/jobs-3/characteristics-of-patients-making-serious-inhaler-errors-with-a-dry-powder-inhaler-and-association-with-asthma-related-events-in-a-primary-care-setting 2024-05-27 https://www.opri.sg/jobs-3/eosinophilic-and-non-eosinophilic-asthma%3A-an-expert-consensus-framework-to-characterize-phenotypes-in-a-global-real-life-severe-asthma-cohort 2024-05-27 https://www.opri.sg/jobs-3/lack-of-asthma-and-rhinitis-control-in-general-practitioner-managed-patients-prescribed-fixed-dose-combination-therapy-in-australia 2024-05-27 https://www.opri.sg/jobs-3/-real-life-effectiveness-and-safety-of-salbutamol-steri-neb%E2%84%A2-vs.-ventolin-nebules%C2%AE-in-preventing-exacerbations-in-patients-with-copd%3A-historical-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/effectiveness-of-same-versus-mixed-asthma-inhaler-devices%3A-a-retrospective-observational-study-in-primary-care 2024-05-27 https://www.opri.sg/jobs-3/characterization-of-copd-in-u.s.-primary-care%3A-data-from-the-optimum-patient-care-with-dartnet-research-database-and-the-embedded-advancing-the-patient-experience-(apex)-in-copd-registry 2024-05-27 https://www.opri.sg/jobs-3/longitudinal-patterns-of-intermittent-oral-corticosteroid-use-for-asthma-in-the-uk 2024-05-27 https://www.opri.sg/jobs-3/harmonizing-the-nomenclature-for-therapeutic-aerosol-particle-size. 2024-05-27 https://www.opri.sg/jobs-3/medication-related-costs-of-rhinitis-in-australia%3A-a-nostradata-cross-sectional-study-of-pharmacy-purchases 2024-05-27 https://www.opri.sg/jobs-3/inhaled-corticosteroids-for-asthma%3A-impact-of-practice-level-device-switching-on-asthma-control 2024-05-27 https://www.opri.sg/jobs-3/first-maintenance-therapy-for-copd-in-the-uk-between-2009-and-2012%3A-a-retrospective-database-analysis 2024-05-27 https://www.opri.sg/jobs-3/association-between-blood-eosinophil-count-and-risk-of-readmission-for-patients-with-asthma%3A-historical-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/excess-costs-associated-with-possible-misdiagnosis-of-alzheimer%E2%80%99s-disease-among-patients-with-vascular-dementia-in-a-uk-cprd-population 2024-05-27 https://www.opri.sg/jobs-3/high-dose-inhaled-corticosteroids-versus-add-on-long-acting-beta-agonists-in-asthma%3A-an-observational-study 2024-05-27 https://www.opri.sg/jobs-3/cluster-analysis-of-inflammatory-biomarker-expression-in-the-international-severe-asthma-registry-(isar) 2024-05-27 https://www.opri.sg/jobs-3/cost-comparison-of-asthma-treatments-in-12-week-study%3A-caution-about-matching-and-short-observational-follow-up 2024-05-27 https://www.opri.sg/jobs-3/a-multinational-observational-study-exposing-the-burden-and-impact-of-self-reported-concomitant-rhinitis-and-identifying-primary-care-patients-at-risk-of-asthma-exacerbations 2024-05-27 https://www.opri.sg/jobs-3/comparison-of-adverse-events-associated-with-different-spacers-used-with-non-extrafine-beclometasone-dipropionate-for-asthma 2024-05-27 https://www.opri.sg/jobs-3/current-control-and-future-risk-in-asthma-management 2024-05-27 https://www.opri.sg/jobs-3/extra-fine-beclometasone-dipropionate%2Fformoterol-fumarate-vs-double-bronchodilation-therapy-in-patients-with-copd%3A-a-historical-real-world-non-inferiority-study 2024-05-27 https://www.opri.sg/jobs-3/longitudinal-patterns-of-intermittent-oral-corticosteroid-use-for-asthma-in-the-uk 2024-05-27 https://www.opri.sg/jobs-3/long-acting-muscarinic-antagonist-use-in-adults-with-asthma%3A-real-life-prescribing-and-outcomes-of-add-on-therapy-with-tiotropium-bromide 2024-05-27 https://www.opri.sg/jobs-3/increased-dose-of-inhaled-corticosteroid-versus-add-on-long-acting-%CE%B2-agonist-for-step-up-therapy-in-asthma 2024-05-27 https://www.opri.sg/jobs-3/reply-to-%E2%80%98%E2%80%98exploring-the-long-term-effects-of-biologic-initiation-in-severe-asthma%3A-insights-from-the-international-severe-asthma-registry%E2%80%99%E2%80%99 2024-05-27 https://www.opri.sg/jobs-3/impact-of-spacers-on-therapeutic-ratio-with-inhaled-corticosteroids 2024-05-27 https://www.opri.sg/jobs-3/budesonide%2Fglycopyrrolate%2Fformoterol-for-the-management-of-copd-in-a-uk-primary-care-population%3A-real-world-use-and-early-medication-success 2024-05-27 https://www.opri.sg/jobs-3/does-co-payment-for-inhaler-devices-affect-therapy-adherence-and-disease-outcomes%3F-a-historical%2C-matched-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/real-world-effectiveness-evaluation-of-budesonide%2Fformoterol-spiromax-for-the-management-of-asthma-and-chronic-obstructive-pulmonary-disease-in-the-uk 2024-05-27 https://www.opri.sg/jobs-3/leukotriene-antagonists-as-first-line-or-add-on-asthma-controller-therapy 2024-05-27 https://www.opri.sg/jobs-3/characteristics-of-patients-preferring-once-daily-controller-therapy-for-asthma-and-copd%3A-a-retrospective-cohort-study 2024-05-27 https://www.opri.sg/jobs-3/-initiating-or-changing-to-a-fixed-dose-combination-of-fluticasone-propionate%2Fformoterol-over-fluticasone-propionate%2Fsalmeterol%3A-a-real-life-effectiveness-and-cost-impact-evaluation 2024-05-27 https://www.opri.sg/jobs-3/-switching-patients-from-other-inhaled-corticosteroid-devices-to-the-easyhaler%C2%AE%3A-historical%2C-matched-cohort-study-of-real-life-asthma-patients 2024-05-27 https://www.opri.sg/jobs-3/a-pragmatic-primary-practice-approach-to-allergy-testing-in-asthma-diagnosis%2C-management%2C-and-referral 2024-05-27 https://www.opri.sg/jobs-3/real-life-effectiveness-and-safety-of-the-inhalation-suspension-budesonide-comparator-vs-the-originator-product-for-the-treatment-of-patients-with-asthma%3A-a-historical-cohort-study-using-a-us-health-claims-database 2024-05-27 https://www.opri.sg/jobs-3/predicting-frequent-asthma-exacerbations-using-blood-eosinophil-count-and-other-patient-data-routinely-available-in-clinical-practice 2024-05-27 https://www.opri.sg/jobs-3/patterns-of-care-in-the-management-of-high-risk-copd-in-the-us-(2011-2019)%3A-an-observational-study-for-the-conquest-quality-improvement-program 2024-05-27 https://www.opri.sg/jobs-3/oral-corticosteroids-in-asthma-and-beyond%3A-moving-forward.-european-respiratory-journal-2022 2024-05-27 https://www.opri.sg/jobs-3/asthma-phenotyping-in-primary-care%3A-applying-the-international-severe-asthma-registry-eosinophil-phenotype-algorithm-across-all-asthma-severities 2024-05-27 https://www.opri.sg/jobs-3/inhaled-corticosteroid-dose-response-on-blood-eosinophils-in-asthma-%E2%80%93-authors%E2%80%99-reply 2024-05-27 https://www.opri.sg/jobs-3/risk-of-pneumonia-in-patients-with-copd-initiating-fixed-dose-inhaled-corticosteroid-(ics)-%2F-long-acting-bronchodilator-(labd)-formulations-containing-extrafine-beclometasone-dipropionate-versus-patients-initiating-labd-without-ics 2024-05-27 https://www.opri.sg/jobs-3/relationship-of-inhaled-corticosteroid-adherence-to-asthma-exacerbations-in-patients-with-moderate-to-severe-asthma 2024-05-27 https://www.opri.sg/jobs-3/association-between-t2-related-co-morbidities-and-effectiveness-of-biologics-in-severe-asthma 2024-05-27 https://www.opri.sg/jobs-3/current-controversies-and-challenges-in-allergic-rhinitis-management 2024-05-27 https://www.opri.sg/jobs-3/ 2024-05-27